Therapeutic applications of reconstituted HDL: When structure meets function.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmacology and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.pharmthera.2015.10.010PMID 26546991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Can phosphatidylserine enhance atheroprotective activities of high-density lipoprotein?

  2016cited by this paper
• HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation

  2015cited by this paper
• Phosphatidylserine potently enhances anti-inflammatory activities of reconstituted HDL

  2015cited by this paper
• HDL particle subpopulations: Focus on biological function

  2015cited by this paper
• Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice.

  2015cited by this paper
• Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.

  2015cited by this paper
• Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.

  2015cited by this paper
• The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.

  2015cited by this paper
• Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]

  2015cited by this paper
• Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

  2014cited by this paper
• Effects of CER-001 on carotid atherosclerosis by 3tmri in homozygous familial hypercholesterolemia (HoFH): The modifying orphan disease evaluation (mode) study

  2014cited by this paper
• A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I

  2014cited by this paper
• Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]

  2014cited by this paper
• N-nervonoylsphingomyelin (C24:1) prevents lateral heterogeneity in cholesterol-containing membranes.

  2014cited by this paper
• CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.

  2014cited by this paper
• CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects

  2014cited by this paper
• High-density lipoprotein, beta cells, and diabetes .

  2014cited by this paper
• Inhibition of Endothelial Lipase Activity by Sphingomyelin in the Lipoproteins

  2014cited by this paper
• Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle

  2014cited by this paper
• Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

  2014cited by this paper
• HDL-targeted therapies: progress, failures and future

  2014cited by this paper
• Sphingomyelin regulation of plasma membrane asymmetry, efflux and reverse cholesterol transport

  2014cited by this paper
• Phospholipids: a novel adjuvant in herbal drug delivery systems.

  2014cited by this paper
• HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

  2014cited by this paper
• Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).

  2014cited by this paper
• Surface code—biophysical signals for apoptotic cell clearance

  2013cited by this paper
• Effect of phospholipid composition on discoidal HDL formation.

  2013cited by this paper
• Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

  2013cited by this paper
• Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung

  2013cited by this paper
• Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle

  2013cited by this paper
• Interaction Between VLDL and Phosphatidylcholine Liposomes Generates New γ-LpE-like Particles

  2013cited by this paper
• Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease

  2013cited by this paper
• High-density lipoproteins: a consensus statement from the National Lipid Association.

  2013cited by this paper
• Down Regulation of MyD88 in Macrophages Treated with Liposomes Composed of Phosphatidylserine

  2013cited by this paper
• Abstract 18589: Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study

  2013cited by this paper
• Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function

  2013cited by this paper
• Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids: Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities

  2013cited by this paper
• Unraveling the complexities of the HDL lipidome1

  2013cited by this paper
• The structural basis of cholesterol accessibility in membranes.

  2013cited by this paper
• Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling

  2013cited by this paper
• Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties.

  2013cited by this paper
• High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics

  2012cited by this paper
• Abstract 11855: CSL112, a Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Healthy Subjects: A, Placebo-Controlled, Double-Blinded, Randomized Single Ascending Dose Study

  2012cited by this paper
• Novel HDL-based therapeutic agents.

  2012cited by this paper
• Phosphatidylserine inhibits and calcium promotes model membrane fusion.

  2012cited by this paper
• An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice[S]

  2012cited by this paper
• Tweaking the cholesterol efflux capacity of reconstituted HDL.

  2012cited by this paper
• High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity

  2012cited by this paper
• Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes.

  2012cited by this paper
• Hydration strongly affects the molecular and electronic structure of membrane phospholipids.

  2012cited by this paper
• Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers[S]

  2012cited by this paper
• Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.

  2011cited by this paper
• Abstract 15525: CER-001, a Synthetic HDL-Mimetic, Safely Mobilizes Cholesterol in Healthy Dyslipidemic Volunteers

  2011cited by this paper
• Phosphoinositides in cell architecture.

  2011cited by this paper
• Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry.

  2011cited by this paper
• Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

  2011cited by this paper
• Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages

  2011cited by this paper
• Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids.

  2011cited by this paper
• Uremia alters HDL composition and function.

  2011cited by this paper
• Pulmonary Surfactant Phosphatidylglycerol Inhibits Mycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages*

  2011cited by this paper
• An overview of sphingolipid metabolism: from synthesis to breakdown.

  2010cited by this paper
• Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevance.

  2010cited by this paper
• Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages

  2010cited by this paper
• Profiling of phospholipids in lipoproteins by multiplexed hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry.

  2010cited by this paper
• Influence of Apolipoprotein (Apo) A-I Structure on Nascent High Density Lipoprotein (HDL) Particle Size Distribution*

  2010cited by this paper
• Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.

  2010cited by this paper
• Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma

  2010cited by this paper
• Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in Mice

  2010cited by this paper
• Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation

  2010cited by this paper
• Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

  2010cited by this paper
• Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function

  2009cited by this paper
• Phosphatidylserine-Containing Liposomes Promote Maximal Survival of Retinal Neurons after Ischemic Injury

  2009cited by this paper
• Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

  2009cited by this paper
• Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano

  2009cited by this paper
• Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis

  2009cited by this paper
• Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?

  2009cited by this paper
• Paraoxonases role in the prevention of cardiovascular diseases

  2009cited by this paper
• Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.

  2009cited by this paper
• HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis

  2009cited by this paper
• Phospholipids as cardiovascular therapeutics.

  2008cited by this paper
• Lipoprotein charge and vascular lipid metabolism.

  2008cited by this paper
• Anti-Inflammatory Action of a Phosphatidylcholine, Phosphatidylethanolamine and N-Acylphosphatidylethanolamine-Enriched Diet in Carrageenan-Induced Pleurisy

  2008cited by this paper
• Membrane lipids: where they are and how they behave

  2008cited by this paper
• Cellular cholesterol trafficking and compartmentalization

  2008cited by this paper
• Membrane recognition by phospholipid-binding domains

  2008cited by this paper
• Hepatic CTP:Phosphocholine Cytidylyltransferase-α Is a Critical Predictor of Plasma High Density Lipoprotein and Very Low Density Lipoprotein*

  2008cited by this paper
• Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion.

  2008cited by this paper
• Dynamic phospholipid signaling by G protein-coupled receptors.

  2007cited by this paper
• ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerols⃞ Published, JLR Papers in Press, December 1, 2006.

  2007cited by this paper
• Nanodiscs unravel the interaction between the SecYEG channel and its cytosolic partner SecA

  2007cited by this paper
• Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARγ‐LXRα‐ABCA1‐dependent pathway associated with apoE

  2007cited by this paper
• Lipoprotein electrostatic properties regulate hepatic lipase association and activity.

  2007cited by this paper
• Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

  2007cited by this paper
• Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid β and interferon-γ-induced microglial activation

  2007cited by this paper
• Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

  2007cited by this paper
• High-density lipoprotein as a therapeutic target: a systematic review.

  2007cited by this paper
• Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities

  2007cited by this paper
• Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE.

  2007cited by this paper
• Spontaneous reconstitution of discoidal HDL from sphingomyelin-containing model membranes by apolipoprotein A-I Published, JLR Papers in Press, January 15, 2007.

  2007cited by this paper
• Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation.

  2007cited by this paper

• Production, characterization and biodistribution of therapeutic high-density lipoprotein-like nanoparticles reconstituted with or without histidine-tagged recombinant ApoA1.

  2025cites this paper
• Radiolabeling lipoproteins to study and manage disease

  2025cites this paper
• High-density lipoprotein-based nanoplatforms for macrophage-targeted diagnosis and therapy of atherosclerosis.

  2025cites this paper
• Adipose tissue targeted sequential delivery system regulating glycolipid metabolism for systemic obesity and its comorbidities

  2024cites this paper
• Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia.

  2023cites this paper
• Enhancement of Anti-inflammatory Effects of Synthetic High-Density Lipoproteins by Incorporation of Anionic Lipids.

  2023cites this paper
• Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease

  2023cites this paper
• Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

  2022cites this paper
• Integrated Quantitative Targeted Lipidomics and Proteomics Reveal Unique Fingerprints of Multiple Metabolic Conditions

  2022cites this paper
• Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI

  2022cites this paper
• Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities

  2022cites this paper
• HDL and Therapy.

  2022cites this paper
• Beyond HDL-Cholesterol: The Search for Functional Biomarkers of High Density Lipoproteins

  2022cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation

  2021cites this paper
• CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction

  2021cites this paper
• Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins

  2021cites this paper
• The antithetic role of ceramide and sphingosine‐1‐phosphate in cardiac dysfunction

  2021cites this paper
• Apolipoprotein M: Research Progress and Clinical Perspective.

  2020cites this paper
• Protein Backbone and Average Particle Dynamics in Reconstituted Discoidal and Spherical HDL Probed by Hydrogen Deuterium Exchange and Elastic Incoherent Neutron Scattering

  2020cites this paper
• Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology.

  2020cites this paper
• Materno-fetal cholesterol transport during pregnancy.

  2020cites this paper
• Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease

  2020cites this paper
• Dataset of the construction and characterization of stable biological nanoparticles

  2020cites this paper
• High-density lipoprotein's vascular protective functions in metabolic and cardiovascular disease - could extracellular vesicles be at play?

  2020cites this paper
• Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.

  2020cites this paper
• Novel Associations between Related Proteins and Cellular Effects of High-Density Lipoprotein

  2019cites this paper
• Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research

  2019influential citation
• The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.

  2019cites this paper
• Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome

  2018cites this paper
• Steroid Transport, Local Synthesis, and Signaling within the Brain: Roles in Neurogenesis, Neuroprotection, and Sexual Behaviors

  2018cites this paper
• Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.

  2018cites this paper
• Enhanced Antiatherosclerotic Efficacy of Statin-Loaded Reconstituted High-Density Lipoprotein via Ganglioside GM1 Modification.

  2018cites this paper
• Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis

  2018influential citation
• Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes.

  2018cites this paper
• Pharmacological Intervention to Modulate HDL: What Do We Target?

  2018cites this paper
• Emerging Phenotypes of Type 2 Diabetes

  2018cites this paper
• Strategies for Functionalizing Lipoprotein-Based Nanoparticles

  2017cites this paper
• Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.

  2017cites this paper
• A facile method for isolation of recombinant human apolipoprotein A-I from E. coli.

  2017cites this paper
• The Detection of HDL receptor on platelet surface in patients with Coronary artery disease (CAD)

  2017cites this paper
• Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.

  2016influential citation
• Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.

  2016cites this paper
• Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio

  2016cites this paper
• Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy.

  2016cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology

  year unknowncites this paper